Oral Contraceptive-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Oral Contraceptive-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Oral Contraceptive industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Oral Contraceptive 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Oral Contraceptive worldwide and market share by regions, with company and product introduction, position in the Oral Contraceptive market
Market status and development trend of Oral Contraceptive by types and applications
Cost and profit status of Oral Contraceptive, and marketing status
Market growth drivers and challenges
The report segments the global Oral Contraceptive market as:
Global Oral Contraceptive Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Oral Contraceptive Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Combination
Progestin Only
Others
Global Oral Contraceptive Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
Global Oral Contraceptive Market: Manufacturers Segment Analysis (Company and Product introduction, Oral Contraceptive Sales Volume, Revenue, Price and Gross Margin):
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oral Contraceptive-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Oral Contraceptive industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Oral Contraceptive 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Oral Contraceptive worldwide and market share by regions, with company and product introduction, position in the Oral Contraceptive market
Market status and development trend of Oral Contraceptive by types and applications
Cost and profit status of Oral Contraceptive, and marketing status
Market growth drivers and challenges
The report segments the global Oral Contraceptive market as:
Global Oral Contraceptive Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Oral Contraceptive Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Combination
Progestin Only
Others
Global Oral Contraceptive Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
Global Oral Contraceptive Market: Manufacturers Segment Analysis (Company and Product introduction, Oral Contraceptive Sales Volume, Revenue, Price and Gross Margin):
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ORAL CONTRACEPTIVE
1.1 Definition of Oral Contraceptive in This Report
1.2 Commercial Types of Oral Contraceptive
1.2.1 Combination
1.2.2 Progestin Only
1.2.3 Others
1.3 Downstream Application of Oral Contraceptive
1.3.1 Male
1.3.2 Female
1.4 Development History of Oral Contraceptive
1.5 Market Status and Trend of Oral Contraceptive 2013-2023
1.5.1 Global Oral Contraceptive Market Status and Trend 2013-2023
1.5.2 Regional Oral Contraceptive Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Oral Contraceptive 2013-2017
2.2 Sales Market of Oral Contraceptive by Regions
2.2.1 Sales Volume of Oral Contraceptive by Regions
2.2.2 Sales Value of Oral Contraceptive by Regions
2.3 Production Market of Oral Contraceptive by Regions
2.4 Global Market Forecast of Oral Contraceptive 2018-2023
2.4.1 Global Market Forecast of Oral Contraceptive 2018-2023
2.4.2 Market Forecast of Oral Contraceptive by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Oral Contraceptive by Types
3.2 Sales Value of Oral Contraceptive by Types
3.3 Market Forecast of Oral Contraceptive by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Oral Contraceptive by Downstream Industry
4.2 Global Market Forecast of Oral Contraceptive by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Oral Contraceptive Market Status by Countries
5.1.1 North America Oral Contraceptive Sales by Countries (2013-2017)
5.1.2 North America Oral Contraceptive Revenue by Countries (2013-2017)
5.1.3 United States Oral Contraceptive Market Status (2013-2017)
5.1.4 Canada Oral Contraceptive Market Status (2013-2017)
5.1.5 Mexico Oral Contraceptive Market Status (2013-2017)
5.2 North America Oral Contraceptive Market Status by Manufacturers
5.3 North America Oral Contraceptive Market Status by Type (2013-2017)
5.3.1 North America Oral Contraceptive Sales by Type (2013-2017)
5.3.2 North America Oral Contraceptive Revenue by Type (2013-2017)
5.4 North America Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Oral Contraceptive Market Status by Countries
6.1.1 Europe Oral Contraceptive Sales by Countries (2013-2017)
6.1.2 Europe Oral Contraceptive Revenue by Countries (2013-2017)
6.1.3 Germany Oral Contraceptive Market Status (2013-2017)
6.1.4 UK Oral Contraceptive Market Status (2013-2017)
6.1.5 France Oral Contraceptive Market Status (2013-2017)
6.1.6 Italy Oral Contraceptive Market Status (2013-2017)
6.1.7 Russia Oral Contraceptive Market Status (2013-2017)
6.1.8 Spain Oral Contraceptive Market Status (2013-2017)
6.1.9 Benelux Oral Contraceptive Market Status (2013-2017)
6.2 Europe Oral Contraceptive Market Status by Manufacturers
6.3 Europe Oral Contraceptive Market Status by Type (2013-2017)
6.3.1 Europe Oral Contraceptive Sales by Type (2013-2017)
6.3.2 Europe Oral Contraceptive Revenue by Type (2013-2017)
6.4 Europe Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Oral Contraceptive Market Status by Countries
7.1.1 Asia Pacific Oral Contraceptive Sales by Countries (2013-2017)
7.1.2 Asia Pacific Oral Contraceptive Revenue by Countries (2013-2017)
7.1.3 China Oral Contraceptive Market Status (2013-2017)
7.1.4 Japan Oral Contraceptive Market Status (2013-2017)
7.1.5 India Oral Contraceptive Market Status (2013-2017)
7.1.6 Southeast Asia Oral Contraceptive Market Status (2013-2017)
7.1.7 Australia Oral Contraceptive Market Status (2013-2017)
7.2 Asia Pacific Oral Contraceptive Market Status by Manufacturers
7.3 Asia Pacific Oral Contraceptive Market Status by Type (2013-2017)
7.3.1 Asia Pacific Oral Contraceptive Sales by Type (2013-2017)
7.3.2 Asia Pacific Oral Contraceptive Revenue by Type (2013-2017)
7.4 Asia Pacific Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Oral Contraceptive Market Status by Countries
8.1.1 Latin America Oral Contraceptive Sales by Countries (2013-2017)
8.1.2 Latin America Oral Contraceptive Revenue by Countries (2013-2017)
8.1.3 Brazil Oral Contraceptive Market Status (2013-2017)
8.1.4 Argentina Oral Contraceptive Market Status (2013-2017)
8.1.5 Colombia Oral Contraceptive Market Status (2013-2017)
8.2 Latin America Oral Contraceptive Market Status by Manufacturers
8.3 Latin America Oral Contraceptive Market Status by Type (2013-2017)
8.3.1 Latin America Oral Contraceptive Sales by Type (2013-2017)
8.3.2 Latin America Oral Contraceptive Revenue by Type (2013-2017)
8.4 Latin America Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Oral Contraceptive Market Status by Countries
9.1.1 Middle East and Africa Oral Contraceptive Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Oral Contraceptive Revenue by Countries (2013-2017)
9.1.3 Middle East Oral Contraceptive Market Status (2013-2017)
9.1.4 Africa Oral Contraceptive Market Status (2013-2017)
9.2 Middle East and Africa Oral Contraceptive Market Status by Manufacturers
9.3 Middle East and Africa Oral Contraceptive Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Oral Contraceptive Sales by Type (2013-2017)
9.3.2 Middle East and Africa Oral Contraceptive Revenue by Type (2013-2017)
9.4 Middle East and Africa Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRACEPTIVE
10.1 Global Economy Situation and Trend Overview
10.2 Oral Contraceptive Downstream Industry Situation and Trend Overview
CHAPTER 11 ORAL CONTRACEPTIVE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Oral Contraceptive by Major Manufacturers
11.2 Production Value of Oral Contraceptive by Major Manufacturers
11.3 Basic Information of Oral Contraceptive by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Oral Contraceptive Major Manufacturer
11.3.2 Employees and Revenue Level of Oral Contraceptive Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ORAL CONTRACEPTIVE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer, Inc.
12.1.1 Company profile
12.1.2 Representative Oral Contraceptive Product
12.1.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Pfizer, Inc.
12.2 Bayer AG
12.2.1 Company profile
12.2.2 Representative Oral Contraceptive Product
12.2.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Bayer AG
12.3 Merck & Co., Inc.
12.3.1 Company profile
12.3.2 Representative Oral Contraceptive Product
12.3.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
12.4 Janssen Global Services, LLC
12.4.1 Company profile
12.4.2 Representative Oral Contraceptive Product
12.4.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Janssen Global Services, LLC
12.5 Mankind Pharma Ltd.
12.5.1 Company profile
12.5.2 Representative Oral Contraceptive Product
12.5.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Mankind Pharma Ltd.
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Company profile
12.6.2 Representative Oral Contraceptive Product
12.6.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries Ltd
12.7 Allergan, plc (Actavis)
12.7.1 Company profile
12.7.2 Representative Oral Contraceptive Product
12.7.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Allergan, plc (Actavis)
12.8 Piramal Enterprises Ltd.
12.8.1 Company profile
12.8.2 Representative Oral Contraceptive Product
12.8.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Piramal Enterprises Ltd.
12.9 Beijing Zizhu Pharm
12.9.1 Company profile
12.9.2 Representative Oral Contraceptive Product
12.9.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Beijing Zizhu Pharm
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRACEPTIVE
13.1 Industry Chain of Oral Contraceptive
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRACEPTIVE
14.1 Cost Structure Analysis of Oral Contraceptive
14.2 Raw Materials Cost Analysis of Oral Contraceptive
14.3 Labor Cost Analysis of Oral Contraceptive
14.4 Manufacturing Expenses Analysis of Oral Contraceptive
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Oral Contraceptive in This Report
1.2 Commercial Types of Oral Contraceptive
1.2.1 Combination
1.2.2 Progestin Only
1.2.3 Others
1.3 Downstream Application of Oral Contraceptive
1.3.1 Male
1.3.2 Female
1.4 Development History of Oral Contraceptive
1.5 Market Status and Trend of Oral Contraceptive 2013-2023
1.5.1 Global Oral Contraceptive Market Status and Trend 2013-2023
1.5.2 Regional Oral Contraceptive Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Oral Contraceptive 2013-2017
2.2 Sales Market of Oral Contraceptive by Regions
2.2.1 Sales Volume of Oral Contraceptive by Regions
2.2.2 Sales Value of Oral Contraceptive by Regions
2.3 Production Market of Oral Contraceptive by Regions
2.4 Global Market Forecast of Oral Contraceptive 2018-2023
2.4.1 Global Market Forecast of Oral Contraceptive 2018-2023
2.4.2 Market Forecast of Oral Contraceptive by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Oral Contraceptive by Types
3.2 Sales Value of Oral Contraceptive by Types
3.3 Market Forecast of Oral Contraceptive by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Oral Contraceptive by Downstream Industry
4.2 Global Market Forecast of Oral Contraceptive by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Oral Contraceptive Market Status by Countries
5.1.1 North America Oral Contraceptive Sales by Countries (2013-2017)
5.1.2 North America Oral Contraceptive Revenue by Countries (2013-2017)
5.1.3 United States Oral Contraceptive Market Status (2013-2017)
5.1.4 Canada Oral Contraceptive Market Status (2013-2017)
5.1.5 Mexico Oral Contraceptive Market Status (2013-2017)
5.2 North America Oral Contraceptive Market Status by Manufacturers
5.3 North America Oral Contraceptive Market Status by Type (2013-2017)
5.3.1 North America Oral Contraceptive Sales by Type (2013-2017)
5.3.2 North America Oral Contraceptive Revenue by Type (2013-2017)
5.4 North America Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Oral Contraceptive Market Status by Countries
6.1.1 Europe Oral Contraceptive Sales by Countries (2013-2017)
6.1.2 Europe Oral Contraceptive Revenue by Countries (2013-2017)
6.1.3 Germany Oral Contraceptive Market Status (2013-2017)
6.1.4 UK Oral Contraceptive Market Status (2013-2017)
6.1.5 France Oral Contraceptive Market Status (2013-2017)
6.1.6 Italy Oral Contraceptive Market Status (2013-2017)
6.1.7 Russia Oral Contraceptive Market Status (2013-2017)
6.1.8 Spain Oral Contraceptive Market Status (2013-2017)
6.1.9 Benelux Oral Contraceptive Market Status (2013-2017)
6.2 Europe Oral Contraceptive Market Status by Manufacturers
6.3 Europe Oral Contraceptive Market Status by Type (2013-2017)
6.3.1 Europe Oral Contraceptive Sales by Type (2013-2017)
6.3.2 Europe Oral Contraceptive Revenue by Type (2013-2017)
6.4 Europe Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Oral Contraceptive Market Status by Countries
7.1.1 Asia Pacific Oral Contraceptive Sales by Countries (2013-2017)
7.1.2 Asia Pacific Oral Contraceptive Revenue by Countries (2013-2017)
7.1.3 China Oral Contraceptive Market Status (2013-2017)
7.1.4 Japan Oral Contraceptive Market Status (2013-2017)
7.1.5 India Oral Contraceptive Market Status (2013-2017)
7.1.6 Southeast Asia Oral Contraceptive Market Status (2013-2017)
7.1.7 Australia Oral Contraceptive Market Status (2013-2017)
7.2 Asia Pacific Oral Contraceptive Market Status by Manufacturers
7.3 Asia Pacific Oral Contraceptive Market Status by Type (2013-2017)
7.3.1 Asia Pacific Oral Contraceptive Sales by Type (2013-2017)
7.3.2 Asia Pacific Oral Contraceptive Revenue by Type (2013-2017)
7.4 Asia Pacific Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Oral Contraceptive Market Status by Countries
8.1.1 Latin America Oral Contraceptive Sales by Countries (2013-2017)
8.1.2 Latin America Oral Contraceptive Revenue by Countries (2013-2017)
8.1.3 Brazil Oral Contraceptive Market Status (2013-2017)
8.1.4 Argentina Oral Contraceptive Market Status (2013-2017)
8.1.5 Colombia Oral Contraceptive Market Status (2013-2017)
8.2 Latin America Oral Contraceptive Market Status by Manufacturers
8.3 Latin America Oral Contraceptive Market Status by Type (2013-2017)
8.3.1 Latin America Oral Contraceptive Sales by Type (2013-2017)
8.3.2 Latin America Oral Contraceptive Revenue by Type (2013-2017)
8.4 Latin America Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Oral Contraceptive Market Status by Countries
9.1.1 Middle East and Africa Oral Contraceptive Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Oral Contraceptive Revenue by Countries (2013-2017)
9.1.3 Middle East Oral Contraceptive Market Status (2013-2017)
9.1.4 Africa Oral Contraceptive Market Status (2013-2017)
9.2 Middle East and Africa Oral Contraceptive Market Status by Manufacturers
9.3 Middle East and Africa Oral Contraceptive Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Oral Contraceptive Sales by Type (2013-2017)
9.3.2 Middle East and Africa Oral Contraceptive Revenue by Type (2013-2017)
9.4 Middle East and Africa Oral Contraceptive Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRACEPTIVE
10.1 Global Economy Situation and Trend Overview
10.2 Oral Contraceptive Downstream Industry Situation and Trend Overview
CHAPTER 11 ORAL CONTRACEPTIVE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Oral Contraceptive by Major Manufacturers
11.2 Production Value of Oral Contraceptive by Major Manufacturers
11.3 Basic Information of Oral Contraceptive by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Oral Contraceptive Major Manufacturer
11.3.2 Employees and Revenue Level of Oral Contraceptive Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ORAL CONTRACEPTIVE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer, Inc.
12.1.1 Company profile
12.1.2 Representative Oral Contraceptive Product
12.1.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Pfizer, Inc.
12.2 Bayer AG
12.2.1 Company profile
12.2.2 Representative Oral Contraceptive Product
12.2.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Bayer AG
12.3 Merck & Co., Inc.
12.3.1 Company profile
12.3.2 Representative Oral Contraceptive Product
12.3.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
12.4 Janssen Global Services, LLC
12.4.1 Company profile
12.4.2 Representative Oral Contraceptive Product
12.4.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Janssen Global Services, LLC
12.5 Mankind Pharma Ltd.
12.5.1 Company profile
12.5.2 Representative Oral Contraceptive Product
12.5.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Mankind Pharma Ltd.
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Company profile
12.6.2 Representative Oral Contraceptive Product
12.6.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries Ltd
12.7 Allergan, plc (Actavis)
12.7.1 Company profile
12.7.2 Representative Oral Contraceptive Product
12.7.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Allergan, plc (Actavis)
12.8 Piramal Enterprises Ltd.
12.8.1 Company profile
12.8.2 Representative Oral Contraceptive Product
12.8.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Piramal Enterprises Ltd.
12.9 Beijing Zizhu Pharm
12.9.1 Company profile
12.9.2 Representative Oral Contraceptive Product
12.9.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Beijing Zizhu Pharm
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRACEPTIVE
13.1 Industry Chain of Oral Contraceptive
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRACEPTIVE
14.1 Cost Structure Analysis of Oral Contraceptive
14.2 Raw Materials Cost Analysis of Oral Contraceptive
14.3 Labor Cost Analysis of Oral Contraceptive
14.4 Manufacturing Expenses Analysis of Oral Contraceptive
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
